Literature DB >> 26926842

Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis.

Changlin Qi1, Yuxing Shan1, Jing Wang1, Fupeng Ding1, Ding Zhao1, Teng Yang1, Yanfang Jiang1,2,3.   

Abstract

The purpose of this study was to examine the roles of T helper 9 (Th9) cells and the serum interleukin (IL)-9 level in the pathogenesis of osteoarthritis (OA). The numbers of IL-9(+) CD4(+) CD8(-) T cells, interferon (IFN)-γ+ CD4(+) CD8(-) T cells, IL-4(+) CD4(+) CD8(-) T cells, and IL-17A(+) CD4(+) CD8(-) T cells in 25 OA patients and 13 healthy controls (HC) were examined by flow cytometry. The serum concentrations of IL-9, IL-4, IL-17A, and IFN-γ were also determined. The numbers of CD4(+) CD45RO(+) T cells, Th9 cells, Th1 cells, and Th17 cells in OA patients were significantly higher than those in HCs. Furthermore, serum IL-9, IL-17A, and IFN-γ levels in OA patients were higher than those in HCs. The number of Th9 cells was positively correlated with the number of Th17 cells in OA patients. Furthermore, greater numbers of Th9 cells were positively associated with elevated C-reactive protein, and both Th9 cells and IL-9 levels were positively correlated with the Western Ontario and McMaster Universities Osteoarthritis index in OA patients. Th9 cell numbers and IL-9 levels are correlated with OA patient symptoms and joint functionality and may be a marker of disease activity.
© 2016 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Th9 cells; WOMAC; interleukin-9; osteoarthritis

Mesh:

Substances:

Year:  2016        PMID: 26926842     DOI: 10.1111/1440-1681.12567

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  9 in total

Review 1.  Immune Contributions to Osteoarthritis.

Authors:  Erika Barboza Prado Lopes; Adrian Filiberti; Syed Ali Husain; Mary Beth Humphrey
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

Review 2.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

3.  A predominant Th1 polarization is present in synovial fluid of end-stage osteoarthritic knee joints: analysis of peripheral blood, synovial fluid and synovial membrane.

Authors:  N Rosshirt; S Hagmann; E Tripel; T Gotterbarm; J Kirsch; F Zeifang; H-M Lorenz; T Tretter; B Moradi
Journal:  Clin Exp Immunol       Date:  2018-11-22       Impact factor: 4.330

Review 4.  [The role of helper T cell in the pathogenesis of osteoarthritis].

Authors:  Dinglong Yang; Zhiqiang Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-07-15

Review 5.  T Cells in Osteoarthritis: Alterations and Beyond.

Authors:  Yu-Sheng Li; Wei Luo; Shou-An Zhu; Guang-Hua Lei
Journal:  Front Immunol       Date:  2017-03-30       Impact factor: 7.561

6.  Th9 Cells in Peripheral Blood Increased in Patients with Immune-Related Pancytopenia.

Authors:  Qing Shao; Yangyang Wang; Zhaoyun Liu; Hui Liu; Yihao Wang; Yang Zhao; Lijuan Li; Rong Fu
Journal:  J Immunol Res       Date:  2020-05-05       Impact factor: 4.818

7.  Elevated frequencies of total and MAIT cell subsets in patients with knee osteoarthritis.

Authors:  Ding Zhao; Wei Zhong; Dongfeng Han; Yingbo Li; Yanfang Jiang; Guishan Gu
Journal:  PeerJ       Date:  2019-08-05       Impact factor: 2.984

8.  Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients.

Authors:  Jessica Feldt; Anna-Jasmina Donaubauer; Jessica Welss; Ulrich Schneider; Udo S Gaipl; Friedrich Paulsen
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

Review 9.  Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics.

Authors:  Zhentian Wei; Feng Li; Guofu Pi
Journal:  Front Cell Infect Microbiol       Date:  2022-03-16       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.